| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The global distribution of the Duffy blood group.
|
Nat Commun
|
2011
|
2.06
|
|
2
|
Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries.
|
Am J Trop Med Hyg
|
2008
|
1.98
|
|
3
|
Which malaria rapid test for Madagascar? Field and laboratory evaluation of three tests and expert microscopy of samples from suspected malaria patients in Madagascar.
|
Am J Trop Med Hyg
|
2007
|
1.91
|
|
4
|
Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
|
Malar J
|
2013
|
1.89
|
|
5
|
Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.
|
Antimicrob Agents Chemother
|
2008
|
1.86
|
|
6
|
Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.
|
Antimicrob Agents Chemother
|
2009
|
1.70
|
|
7
|
Mapping the aetiology of non-malarial febrile illness in Southeast Asia through a systematic review--terra incognita impairing treatment policies.
|
PLoS One
|
2012
|
1.56
|
|
8
|
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
|
Am J Trop Med Hyg
|
2014
|
1.51
|
|
9
|
Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.
|
Malar J
|
2014
|
1.49
|
|
10
|
Country-wide assessment of the genetic polymorphism in Plasmodium falciparum and Plasmodium vivax antigens detected with rapid diagnostic tests for malaria.
|
Malar J
|
2008
|
1.34
|
|
11
|
Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.
|
Malar J
|
2013
|
1.27
|
|
12
|
Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.
|
Malar J
|
2008
|
1.25
|
|
13
|
Extrapulmonary and pulmonary tuberculosis in antananarivo (madagascar): high clustering rate in female patients.
|
J Clin Microbiol
|
2002
|
1.19
|
|
14
|
Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.
|
Am J Trop Med Hyg
|
2010
|
1.18
|
|
15
|
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.
|
Antimicrob Agents Chemother
|
2013
|
1.15
|
|
16
|
G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients.
|
Malar J
|
2013
|
1.10
|
|
17
|
Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.
|
PLoS One
|
2010
|
1.09
|
|
18
|
Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study.
|
Malar J
|
2014
|
1.07
|
|
19
|
Multiple independent introductions of Plasmodium falciparum in South America.
|
Proc Natl Acad Sci U S A
|
2011
|
1.06
|
|
20
|
Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children.
|
Malar J
|
2006
|
1.04
|
|
21
|
Cocirculation of measles virus genotype B2 and B3.1 in Central African Republic during the 2000 measles epidemic.
|
J Med Virol
|
2006
|
1.03
|
|
22
|
Short report: prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar.
|
Am J Trop Med Hyg
|
2007
|
1.02
|
|
23
|
Evaluation of two new immunochromatographic assays for diagnosis of malaria.
|
Am J Trop Med Hyg
|
2008
|
0.99
|
|
24
|
Management of uncomplicated malaria in febrile under five-year-old children by community health workers in Madagascar: reliability of malaria rapid diagnostic tests.
|
Malar J
|
2012
|
0.99
|
|
25
|
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.
|
BMC Med
|
2015
|
0.99
|
|
26
|
Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Bangui, Central African Republic.
|
J Antimicrob Chemother
|
2003
|
0.97
|
|
27
|
Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar.
|
Am J Trop Med Hyg
|
2012
|
0.96
|
|
28
|
Performance of "VIKIA Malaria Ag Pf/Pan" (IMACCESS®), a new malaria rapid diagnostic test for detection of symptomatic malaria infections.
|
Malar J
|
2012
|
0.95
|
|
29
|
HIV epidemic in Central African Republic: high prevalence rates in both rural and urban areas.
|
J Med Virol
|
2004
|
0.94
|
|
30
|
High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
|
Am J Trop Med Hyg
|
2009
|
0.94
|
|
31
|
Individual Plasmodium vivax msp1 variants within polyclonal P. vivax infections display different propensities for relapse.
|
J Clin Microbiol
|
2012
|
0.93
|
|
32
|
Rapid detection of point mutations in Plasmodium falciparum genes associated with antimalarial drugs resistance by using High-Resolution Melting analysis.
|
J Microbiol Methods
|
2009
|
0.93
|
|
33
|
History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar.
|
Scand J Infect Dis
|
2010
|
0.92
|
|
34
|
Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene.
|
Antimicrob Agents Chemother
|
2011
|
0.87
|
|
35
|
Effects of mefloquine use on Plasmodium vivax multidrug resistance.
|
Emerg Infect Dis
|
2014
|
0.86
|
|
36
|
In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum.
|
Malar J
|
2011
|
0.86
|
|
37
|
Dihydrofolate reductase I164L mutation in Plasmodium falciparum, Madagascar.
|
Emerg Infect Dis
|
2008
|
0.84
|
|
38
|
In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.
|
J Biol Chem
|
2013
|
0.81
|
|
39
|
Origins of the recent emergence of Plasmodium falciparum pyrimethamine resistance alleles in Madagascar.
|
Antimicrob Agents Chemother
|
2010
|
0.81
|
|
40
|
Plasmodium falciparum Na+/H+ exchanger (pfnhe-1) genetic polymorphism in Indian Ocean malaria-endemic areas.
|
Am J Trop Med Hyg
|
2012
|
0.77
|
|
41
|
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.
|
Emerg Infect Dis
|
2017
|
0.75
|
|
42
|
Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay.
|
Arch Virol
|
2007
|
0.75
|
|
43
|
Patterns of selection on Plasmodium falciparum erythrocyte-binding antigens after the colonization of the New World.
|
Mol Ecol
|
2014
|
0.75
|